AIP
PMI

Ameritas Investment Partners’s Picard Medical PMI Stock Holding History

Ameritas Investment Partners’s Portfolio PMI Stock Details PMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8
Closed -$418 – 3369
2026
Q1 		$418 Hold
8
– – ﹤0.01% 3098
2025
Q4 		$704 Buy
+8
New +$1.88K ﹤0.01% 3119

Other funds holding PMI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
PCA
Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return

Ameritas Investment Partners's PMI Position: Q2 2026 in Review

Ameritas Investment Partners sold out of Picard Medical (PMI) in Q2 2026, closing a stake of 8 shares — an estimated $418 sold.

Ameritas Investment Partners first reported a position in PMI in Q4 2025 and held it in 2 quarters. The position peaked at $704 in Q4 2025. 34 funds tracked by Wall St. Rank hold PMI as of Q2 2026.

  • Ameritas Investment Partners reported no remaining Picard Medical position as of Q2 2026 after selling out during the quarter.
  • Ameritas Investment Partners sold 8 Picard Medical shares in Q2 2026, an estimated $418.
  • Ameritas Investment Partners first reported a position in Picard Medical in Q4 2025 and held it in 2 quarters.
  • Ameritas Investment Partners's Picard Medical position peaked at $704 in Q4 2025.
  • 34 funds tracked by Wall St. Rank held Picard Medical as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.